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The characterization of a specific Thy-1 molecular epitope ex-
pressed on rat mesangial cells.
Background. An Experimental model of proliferative
glomerulonephritis induced by an antibody against Thy-1 anti-
gen has been established. However, the pathophysiologic role
and the critical epitope of Thy-1 molecule for induction of
mesangial cell dysfunction remain unknown. We have reported
that monoclonal antibody 1-22-3 recognizes specific epitope
which could transduce highly effective activation in mesan-
gial cells. Identification of functional domains on cell surfaces
is indispensable for understanding the molecular mechanisms
of mesangial cell function. This study was undertaken to de-
termine the functional domain containing the specific epitope
recognized by monoclonal antibody 1-22-3.
Methods. A series of glutathione-S-transferase (GST)-
truncated-Thy-1 proteins were generated using pGEX 4T-1 vec-
tor. COS cells were transiently transfected with plasmid vectors
which could express the rat Thy-1 and mutant-Thy-1.
Results. Western blot analysis using recombinant GST-
truncated-Thy-1 revealed that 1-22-3 bound to epitope at amino
acids 15–23 (LRLDCRHEN). Enzyme-linked immunosorbent
assay (ELISA) revealed that synthetic LRLDCRHEN pep-
tides could inhibit the binding of 1-22-3 to rat mesangial cells
and GST-Thy-1 protein. Using peptides as antigens, ELISA
showed that 1-22-3 bound to the LRLDCRHEN but not to
the RVNLFSDRF, which was corresponding to at amino acids
59–67 of rat Thy-1. 1-22-3 could bind the COS cells which ex-
press rat Thy-1 proteins, but could not bind rat truncated-Thy-1
which lacks residues 15–23.
Conclusion. Critical epitope detected by 1-22-3 in this study
may play an important role in mesangial function and injury.
Since the concept of immunoglobulin superfamilies
was proposed in 1982 [1], over 70 members have been
added to the list, largely on the basis of sequence ho-
mology. There are many different functions of the family,
including receptors for immunoglobulins (for example,
CD16, CD89), receptors for growth factors [platelet-
derived growth factor (PDGF) receptor and colony-
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stimulating factor-1 (CSF-1) receptor), and as adhesion
molecules [carcinoembryonic antigen (CEA) and neural
cell adhesion molecule (NCAM)] [2, 3]. And recently,
the importance of the immunoglobulin superfamily pro-
teins in brain development is elucidated [4, 5]. Thy-1 is a
representative glycoprotein of this superfamily. Thy-1
is anchored to the cell surface via the glycosyl phos-
phatidylinositol (GPI) [6] and is expressed in various cell
types, such as T cells, the neuron system, fibroblasts, and
kidney cells [7].
Thy-1 function remains largely obscure, but it appears
to be involved in cell adhesion and activation in neu-
ral and immune cells. For example, Thy-1 promotes the
adhesion of thymocytes to thymic epithelia [8], the ad-
hesion of cytotoxic T cell (CTL) clones to L cells [9], T
cell activation [10], rat mast cell activation [11], and the
adhesion of a Thy-1–transfected lymphoma to astrocytes
[12]. Thy-1 function on rat mesangial cells is unknown.
Src proteins are associated with rat mesangial Thy-1 and
cross-linking of Thy-1 with antibody cause apoptosis of
rat mesangial cells. From these data, we speculated that
mesangial Thy-1 may act as a functional molecule. It has
also been reported that some anti-Thy-1 monoclonal an-
tibodies were capable of activating T cells, whereas others
were not stimulatory [13]. It can be speculated that bind-
ing of antibodies to particular epitopes could transduce
activation. Recently, we have also reported that two mon-
oclonal antibodies, named OX-7 and 1-22-3, recognize
specific epitopes which could transduce highly effective
activation in mesangial cells [14].
1-22-3 binding is limited to the site of the mesangial cell
surface that faces endothelial cells, and no 1-22-3 reactiv-
ity to mesangial extracellular matrix (ECM) or glomeru-
lar basement membrane (GBM) [15] was detected. By
contrast, it was reported that OX-7 has reactivity toward
the entire surface of mesangial cell and the mesangial
cell matrix [16]. Injection of monoclonal antibody 1-22-3
into rats produced severe mesangiolysis and mesangial
proliferation and much higher urinary protein excretion
than seen with OX-7 [17]. On the basis of these results,
we speculated that the specific Thy-1 epitope recognized
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by 1-22-3 might play an important role in mesangial cell
function and cell communication between mesangial and
endothelial cells.
Identification of functional domains (epitopes) on cell
surfaces is indispensable for understanding the molecular
mechanisms of cell-to-cell interaction via Thy-1 molecule
in physiopathologic settings. This study was undertaken
to determine the functional domain containing the spe-
cific epitope recognized by monoclonal antibody 1-22-
3, using recombinant fusion glutathione-S-transferase
(GST)-Thy-1 proteins and synthetic peptides.
METHODS
Cells and antibodies
Rat mesangial and aortic endothelial cells were
prepared as described previously [18]. Monoclonal anti-
bodies 1-22-3 (IgG3) and OX-7 (IgG1) were produced
in ascitic fluid of Balb/c mice, primed with 2,6,10,14-
tetramethylpentadecane (Sigma Chemical Co., St. Louis,
MO, USA). The fluid was subjected to 50% ammonium
sulfate precipitation, and the immunoglobulin rich
fraction was dialyzed against phosphate-buffered saline
(PBS) for 2 days and stored at −70◦C until use. Control
monoclonal antibodies RVG1 (IgG1) and AD-4 (IgG3),
confirmed to be unreactive with kidney, was also pre-
pared from ascitic fluid as described above. The F(ab’)2
fragments were produced by digestion with pepsin as
follows: monoclonal antibodies at 5 mg/mL in 0.1 mol/L
citrate buffer, pH 3.5(OX-7) or pH 4.5 (1-22-3), were
incubated at 37◦C for 15 minutes (1-22-3) or 24 hours
(OX-7) with pepsin (Worthington Biochemical Co.,
Lakewood, NJ, USA) at a final concentration of 25
lg/mL. The reaction was terminated by raising the
pH to >7.0 by addition of 3.0 mol/L Tris-HCl, pH 8.6.
After dialysis against PBS to remove smaller fragments,
the F(ab’)2 fragments were separated from undigested
monoclonal antibodies by superdex 200 pg gel filtration
chromatography (Amersham Pharmacia, Uppsala, Swe-
den). Aliquots of each fraction were analyzed by sodium
dodecyl sulfate-polyacrylamide gel electrophoresis
(SDS-PAGE) under nonreducing conditions and the
appropriate fractions were collected.
Antirat CD61 (integrin-b 3 chain) monoclonal anti-
body was purchased from Pharmingen (BD Biosciences
Pharmingen, San Diego, CA, USA). Antirat CD31 mono-
clonal antibody was purchased from R&D Systems (San
Diego, CA, USA). Rabbit anti-FLAG polyclonal anti-
body was purchased from Sigma Chemical Co. Antithy-
mocyte serum (ATS) was obtained from the rabbit, which
was immunized with rat thymocytes.
Production of GST-Thy-1 fusion proteins
We constructed pGEXrThy-1 (1–111), pGEXrThy-
1 (1–55), pGEXrThy-1 (51–111), pGEXrThy-1 (1–36),
Table 1. Oligonucleotide primers used in cDNA amplification
Transcript
Primer Sequence
Sense primers
rThy-1ms 5′-AAGAATTCCAGAGGGTGATCAGCCTG-3′
rThy-1s9 5′-AAGAATTCTGCCTGGTGAACCAGAAC-3′
rThy-1s13 5′-AAGAATTCCAGAACCTTCGCCTGGACTG-3′
rThy-1s15 5′-AAGAATTCCTTCGCCTGGACTGCC-3′
rThy-1s16 5′-AAGAATTCCGCCTGGACTGCC-3′
rThy-1s18 5′-AAGAATTCGACTGCCGTCATGAGAAT-3′
rThy-1s51 5′-AAGAATTCCCCGAGCACAACTTACCGC-3′
Antisense primers
rThy-1mas 5′-CTCTCTCGAGACTGAAAAGGTTGAC-3′
rThy-155as 5′-CTCTCTCGAGTAAGTGTGCTCGGG-3′
rThy-136as 5′-CTCTCTCGAGGGGTCAGGCTGAACTC-3′
rThy-128as 5′-CTCTCTCGAGGGGCAAGTTGGTG-3′
rThy-125as 5′-CTCTCTCGAGTCAGGTGTTATTCTCATGAC-3′
rThy-124as 5′-CTCTCTCGAGTCAGTTATTCTCATGAC-3′
rThy-123as 5′-CTCTCTCGAGTCAATTCTCATGAC-3′
rThy-122as 5′-CTCTCTCGAGTCTCATGACGGCAGTC-3′
pGEXrThy-1 (1–22), pGEXrThy-1 (18–36), pGEXr
Thy-1 (9–27), pGEXrThy-1 (13–25), pGEXrThy-1
(15–25), pGEXrThy-1 (15–27), pGEXrThy-1 (16–25),
pGEXrThy-1 (15–23), pGEXrThy-1 (1–24), expression
vectors for GST-Thy-1 fusion molecules, using pGEX4T-
1 vector (Amersham Pharmacia). PGEXrThy-1 (a-b)
represents a vector, which express GST-Thy-1 fusion pro-
tein that included residue a to b of rat Thy-1. Rat mesan-
gial cell mRNA was isolated using the QuickPrep Micro
mRNA Purification Kit (Pharmacia Biotech). Reverse
transcription was performed using First-Strand cDNA
Synthesis Kit (Pharmacia Biotech) according to the man-
ufacturer’s information. Sets of primers carrying EcoRI
and XhoI tags were designed according to each sequence
to produce GST fusion proteins of those proteins. Primer
sequences are listed in Table 1. Polymerase chain reac-
tion (PCR) was carried out in an automated DNA ther-
mal cycler using KOD DNA polymerase (Toyobo, Tokyo,
Japan). The amplification protocol was 1 minute at 94◦C,
1 minute at 50◦C, and 1 minute at 72◦C for 30 cycles. The
PCR products and pGEX4T-1 DNA were digested with
EcoRI and XhoI, ligated to each other, and then used for
transformation of BL-21 cells. Inserted plasmid DNA se-
quences in the transformants were determined using an
ABI Prism310 Genetic Analyzer (Applied Biosystems,
Foster City, CA, USA), and appropriate cells were se-
lected. The sequence of rat mesangial Thy-1 is 100% iden-
tical to that reported for rat Thy-1.1.
Purification of GST-Thy-1 peptide fusion proteins
BL21 cells harboring pGEX-Thy-1 expression con-
structs were induced with 1 mmol/L isopropylthio-
alpha-D-galactoside for 3 hours at 37◦C, harvested by
centrifugation, and resuspended in PBS-0.5% Triton X-
100. The suspensions were then sonicated and subjected
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to centrifugation at 12,000 × g for 10 minutes. The su-
pernatants were filtered with a 0.4 lm filter and then
applied to a glutathione-sepharose 4B column. After ex-
tensive washing the purified GST-Thy-1 proteins were
eluted with 5 mmol/L glutathione in 50 mmol/L Tris-HCl,
pH 8. The purified GST fusion proteins were dialyzed
against PBS and stored at −70◦C until use.
SDS-PAGE and immunoblotting
BL21 cells harboring pGEX-Thy-1 expression con-
structs were induced with 1 mmol/L isopropylthio-
alpha-D-galactoside for 3 hours at 37◦C, harvested by
centrifugation, and resuspended in PBS-0.5% Triton X-
100. Cultured rat mesangial cells were lysed in RIPA
buffer (50 mmol/L Tris-HCl, pH 8.0, 150 mmol/L NaCl,
1% NP-40, 0.5% deoxycholate, 0.1% SDS). The cell
suspensions were mixed with the same volume of 2×
SDS sample buffer. The cell lysate were separated in
12% SDS-polyacrylamide gels. The separated proteins
were electrotransferred to 0.4 lm polyvinylidine difluo-
ride (PVDF) membranes. The membranes were blocked
with 10% milk in PBS-0.05% Tween 20 (PBS-T), pH 7.4,
overnight at 4◦C. After washing with PBS-T, membranes
were incubated with 1 lg/mL of 1-22-3, OX-7, or mouse
IgG at 4◦C overnight. After extensive washing with four
changes of PBS-T, filters were incubated for 1 hour at
37◦C with horseradish peroxidase-conjugated sheep an-
timouse IgG (Bio-Rad, Richmond, CA, USA) at a 1:2000
dilution in blocking buffer. After washing, immunoreac-
tivity was detected by the enhanced chemiluminescence
(ECL) (Amersham Pharmacia) system.
Enzyme-linked immunosorbent assay (ELISA)
Microtiter plates were coated with 50 lL/well of a
14 lg/mL solution of a synthetic peptide in PBS overnight
at 4◦C, washed with PBS-T, and then blocked by 150 lL/
well of 1% bovine serum albumin (BSA) diluted in PBS-T
for 1 hour at room temperature. Ten lg/mL of monoclonal
antibodies 1-22-3, OX-7, and AD-4 were added to each
well and plates were incubated for 1 hour at room tem-
perature. After washing with PBS-T, peroxidase labeled
antimouse IgG F(ab’)2-specific antibody (×3000 in block-
ing buffer) was added. Following a 60-minute incubation
at room temperature, the plates were washed, developed
with o-phenylenediamine dihydrochloride (Sigma Chem-
ical Co.) as per manufacturer’s instructions, and read with
a microtiter plate reader (Bio-Rad) at 492 nm. For block-
ing experiments, rat mesangial cells were cultured on
96-well plates until confluent. Cells were fixed with 1%
paraformaldehyde in 10 mmol/L phosphate buffer, pH
7.2, for 60 minutes and washed with phosphate buffer
and blocked with 0.5% BSA in phosphate buffer at 4◦C
for overnight. Equal volume of 4 lg/mL of 1-22-3 or
OX-7 was mixed with different concentration of syn-
thetic peptide. And the samples were added the each
well and plates were incubated for 60 minutes. After
washing with phosphate buffer, peroxidase-labeled an-
timouse IgG F(ab’)2-specific antibody (×3000 in block-
ing buffer) was added. Following a 60-minute incubation
at room temperature, the plates were washed, developed
with o-phenylenediamine dihydrochloride (Sigma Chem-
ical Co.) as per the manufacturer’s instructions, and read
with a microtiter plate reader (Bio-Rad) at 492 nm.
Cell surface expression of mutated rat thy-1 proteins
on COS cells
For cell surface expression of Thy-1, pCDM8 mam-
malian expression vector was used.
We generated pCDM8rThy-1 (wild-type Thy-1),
pCDM8rThy-1 (18D-E) (rat Thy-1 whose amino acid at
18 residue aspartic acid was changed to glutamic acid),
pCDM8FLAGrThy-1(FLAG-tagged rat Thy-1) and
pCDM8FLAGrThy-1 (15 del) (FLAG-tagged rat Thy-
1 whose amino acid at 15 residue leucine was deleted),
pCDM8FLAG-rThy-1 (15L-E) (FLAG-tagged rat Thy-
1 whose amino acid at 15 residue leucine was replaced
to glutamic acid), and pCDM8FLAGrThy-1(15L-R)
(FLAG-tagged rat Thy-1 whose amino acid at 15 residue
leucine was replaced to arginine). A set of primer carry-
ing XbaI tags was used for generating pCDM8rThy1 con-
struct (forward primer 5′-TAGTCTAGAATCCAGCTA
TTGGCACC-3′, reverse primer 5′-TAGTCTAGATCA
CAGAGAAATGAAGTC-3′). PCR was carried out in
an automated DNA thermal cycler using KOD DNA
polymerase (Toyobo). The amplification protocol was 1
minute at 94◦C, 1 minute at 50◦C, and 1 minute at 72◦C
for 30 cycles. The PCR product and pCDM8 were both
digested with XbaI, ligated each other, and then used for
transformation of MC1063/P3 cells.
Mutated Thy-1 expression vectors were produced by
the method of Imai et al [19] using pCDM8rThy-1 as a
original. Briefly, oligonucleotides primers were designed
in inverted tail-to-tail directions to amplify the vector to-
gether with target sequences. A mutation is generated
by amplification with primers that have a correspond-
ing mutation between their 5′ ends (Table 2). After the
PCR with these primers, amplified linear DNA to self-
ligated, and used to transform MC1063/P3 cells. COS cells
in 35 mm dishes were transfected with plasmid using poly-
fect transfection reagent (Qiagen, Hilden, Germany) fol-
lowing the manufacturer’s instruction. Forty-eight hours
after transfection, COS cells were processed to immuno-
histochemistry.
Immunohistochemistry
COS cell, rat mesangial cells, and rat aortic endothe-
lial cells on culture glass plates were washed twice with
Dulbecco’s modified Eagle’s medium (DMEM) and then
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Table 2. Oligonucleotide primers and cDNA for construction of
mutated Thy-1 expression vectors
pCDM8rThy-1 (18D-E)
cDNA pCDM8rThy-1
Primer 1 5′-TGCGTCATGAGAATAACACC-3′
Primer 2 5′-CTCCAGTCGAAGGTTCTGGTTC-3′
pCDM8FLAGrThy-1
cDNA pCDM8rThy-1
Primer 1 5′-GTCCTTGTAGTCTCCTCGGGACATCT
GCAAGACTG-3′
Primer 2 5′-GACGATGACAAGCAGAGGGTGAT
CAGCCTGACAGC-3′
pCDM8FLAGrThy-1 (15 del)
cDNA pCDM8FLAGrThy-1
Primer 1 5′-CGA CTG GAC TGC CGT CAT GAG-3′
Primer 2 5′-GTT CTG GTT CAC CAG GCA GGC-3′
pCDM8FLAGrThy-1 (15L-R)
cDNA pCDM8FLAGrThy-1
Primer 1 5′-CGA CTG GAC TGC CGT CAT GAG-3′
Primer 2 5′-ACG GTT CTG GTT CAC CAG GCA-3′
pCDM8FLAGrThy-1 (15L-E)
cDNA pCDM8FLAGrThy-1
Primer 1 5′-CGA CTG GAC TGC CGT CAT GAG-3′
Primer 2 5′-GTC GTT CTG GTT CAC CAG GCA-3′
Underlining shows the mutation or insertion sequence.
incubated with first antibody at 37◦C for 30 minutes. After
washing with DMEM, the specimens were incubated with
fluorescein isothiocyanate (FITC)-labeled antimouse or
rabbit IgG at 37◦C for 30 minutes, and washed with
DMEM. For double staining with 1-22-3 and OX-7, living
cultured cells on culture glass plates were washed twice
with DMEM and then incubated with 10 lg/mL 1-22-3
at 37◦C for 30 minutes. After washing with DMEM, the
specimens were incubated with FITC-labeled antimouse
IgG at 37◦C for 30 minutes, washed with DMEM, incu-
bated with the second monoclonal antibody, biotinylated
OX-7, for 30 minutes at 37◦C, again washed with DMEM
and incubated with ExtrAvidin-TRITC conjugate (60
lg/mL) (Sigma Chemical Co.) for 30 minutes at 37◦C.
During all the procedures using living cells, 10 mmol/L
sodium azide was present in the DMEM. Finally, the
treated specimens were mounted in 90% glycerol-PBS
containing 0.1% p-phenylenediamine on glass slides and
examined by use of confocal laser scanning microscope
(MRC 1024) (Bio-Rad).
Measurements of intracellular calcium concentration
Mesangial cells were cultured to 75% confluence on
a glass bottomed culture dish in DMEM with 20% fetal
calf serum (FCS) for 2 to 3 days. Cells were then placed
in DMEM with 0.5% FCS for 48 hours. The cells were
rinsed twice with 2 mL physiologic saline solution (PSS)
(135 mmol/L NaCl, 5.4 mmol/L KCl, 1 mmol/L MgCl2,
1.8 mmol/L CaCl2, 10 mmol/L glucose, and 5 mmol/L
Hepes, pH 7.4). The cells were then loaded with10 lmol/L
fura-2/AM (Dojinn, Kumamoto, Japan) for 40 minutes at
37◦C in PSS. After incubation with fura-2/AM solution,
the dishes were rinsed with PSS and 1 mL of PSS was
added to the each dish. One hundred lL of 1 mg/mL of
F(ab’)2 1-22-3 or OX-7 in PSS was added to each dish.
Calcium imaging was performed on an Argus/Hisca sys-
tem (Hamamatsu Photonics Ltd., Hamamatsu, Japan)
with a Zeiss inverted microscope. Data acquisition and
analysis was performed using the U4469–01 Argus/Hisca
software. For each analysis, the dishes were placed on
the microscope stage and the cells were visualized with a
×20 objective. Images were acquired at preset intervals
of 3 seconds.
Cell-cell adhesion assay
Endothelial cells were plated on a 96-well culture plate
and cultured until confluent. Mesangial cells were cul-
tured in a 75 cm2 flask and cells were labeled with 3H-
thymidine. After labeling, the cells were suspended in
DMEM and incubated with 10 lg/mL of 1-22-3, OX-7,
or AD-4 for 30 minutes at 4◦C. After incubation the cell
suspensions were added to the endothelial cells in a 96-
well plate. After 20 minutes at 37◦C incubation, cells were
gently washed with prewarmed DMEM three times, then
lysed with 1 N NaOH and the radioactivity (DPM) de-
termined by liquid scintillation counting. Relative bind-
ing was calculated as DPM 1-22-3 or OX-7/DPM AD-4
in each experiment. For all experiments, each condition
shown was performed in quadruplicate. The viability of
the mesangial cells was estimated by dye exclusion assay
and there was no significant difference among groups.
Statistical analysis
The results were expressed as mean ± SD, and statis-
tical analysis was performed by Student t test.
RESULTS
Binding of monoclonal antibodies 1-22-3 and
OX-7 to cultured mesangial cells
We examined the distribution of monoclonal antibod-
ies 1-22-3 and OX-7 on cultured mesangial cells. The
immunofluorescence showed similar diffuse, spotted
binding patterns for both 1-22-3 and OX-7. Computer-
aided superimposition of the two pictures enabled us to
differentially localize monoclonal antibodies bound to
the cultured mesangial cells. Nearly all the green-colored
1-22-3 granules on the cell surfaces changed to yellow
when the images were superimposed. Furthermore, bind-
ing of OX-7 to the extracellular region was observed (data
not shown).
Effect of monoclonal antibody 1-22-3 on the function
of mesangial cells
One hundred lg of F(ab’)2 fragment of 1-22-3 or
F(ab’)2 fragment of OX-7 was added to the mesangial
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Fig. 1. Thy-1mediated increase in [Ca2+]i in rat glomerular mesangial cells. Cells were prepared for fura-2 fluorescence measurements of [Ca2
+]i
and maintained in physiologic saline solution (PSS). Calcium imaging was performed on an Argus/Hisca system. Arrow indicates the point of
addition of F(ab’)2 antibody in PSS. [Ca2
+]i change in seven cells were measured in one experiment. The line exhibit the mean [Ca2+]i change
in the seven mesangial cells. At least four experiments were performed. This figure shows one of the representative results. Monoclonal antibody
1-22-3, basal level of 53.4 ± 4.9 to peak level of 112 ± 17.2 nmol/L, 3 minutes after addition 88.7 ± 6.6 nmol/L, 5 minutes after addition 73 ± 9.4
nmol/L (N = 7). Monoclonal antibody OX-7 basal level of 40.4 ± 7.9 nmol/L to peak level of 79 ± 20.3 nmol/L, 3 minutes after antibody addition
44 ± 9.3 nmol/L, 5 minutes after addition 44.3 ± 9.4 nmol/L (N = 7).
cell culture. 1-22-3 induced an increase in [Ca2+]i of the
mesangial cells. The peak was at 112 ± 17.2 nmol/L and
then gradually decreased for 7 to 10 minutes. OX-7 in-
duced a transient increase in [Ca2+]i of the mesangial
cells, at a peak level of 79 ± 20.3 nmol/L (Fig. 1).
Rat aortic endothelial cells were stained with antirat
CD61 (integrin-b 3 chain), antirat CD31 monoclonal anti-
body, and OX-7. Over 95% of cells were endothelial cells
estimated by CD31-positive and less than 5% were OX-7-
positive that means smooth muscle contamination is less
than 5%. There is no positive staining for CD61 on rat en-
dothelial cells (data not shown). Mesangial-endothelial
cell adhesion was partly inhibited by the addition of 1-
22-3, whereas addition of OX-7 had no effect (relative
binding 0.75 ± 0.13 (N = 4) vs. 1.37 ± 0.10 (N = 4) (P <
0.05).
Analysis of the 1-22-3 epitope using
GST-truncated-Thy-1 fusion protein
Western blot analysis showed that both 1-22-3 and OX-
7 reacted with 28 kD Thy-1 molecules in RIPA extracts
of mesangial cells (Fig. 2A). To determine the epitope
recognized by 1-22-3, we generated GST-Thy-1 fusion
proteins. 1-22-3 reacted with GST-Thy-1 (1–111), as well
as with GST-Thy-1 (1–55). There was no reactivity of 1-
22-3 to GST-Thy-1 (51–111). The reactivity of OX-7 to
GST-Thy-1 (1–111) was much greater than with 1-22-3,
whereas OX-7 showed no reactivity to both GST-Thy-
1 (1–55) and GST-Thy-1 (51–111) (Fig. 2B). Then we
generated the GST-truncated-Thy-1s. 1-22-3 reacted with
the first 36 amino acids of the Thy-1 molecules, but with
neither the first 22 amino acids nor the amino acids 18
to 36 of Thy-1 (Fig. 2C). This means that the epitope,
which was recognized by1-22-3, comprises amino acids
18–22 of the Thy-1 molecule. We generated a series of
GST-truncated-Thy-1 peptides (Fig. 2G). 1-22-3 recog-
nizes the minimum sequence of 15 -23 amino acids of
Thy-1 molecules (Fig. 2D to G). OX-7 had no reactivity
to these GST-truncated-Thy-1s and GST-truncated-Thy-
1 peptides (data not shown).
Binding of 1-22-3 to the synthetic peptide
We also examined the reactivity of 1-22-3 and OX-7 to
synthetic peptides corresponding to amino acid residues
15–23 of Thy-1 by ELISA. 1-22-3 reacted with the pep-
tides LRLDCRHEN (corresponding to amino acids 15–
23 of Thy-1) but did not react with the peptide RVNLFS-
DRF (corresponding to amino acids 59–67 of Thy-1),
whereas OX-7 had no reactivity to both peptides (Fig. 3).
Effect of the peptide LRLDCRHEN on the binding of
1-22-3 to Thy-1 and mesangial cells
To test the effect of synthetic peptide LRLDCRHEN
on the binding of 1-22-3 to mesangial cells, the synthetic
peptides were added to the cellular ELISA system. The
peptides LRLDCRHEN could block the binding of 1-
22-3 to the mesangial cells in a dose-dependent manner.
However, the peptide RVNLFSDRF had no effect on the
binding of 1-22-3 to the mesangial cells (Fig. 4). Both pep-
tides could not block the binding of OX-7 to mesangial
cells.
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Fig. 2. Westernblot analysis of Thy-1 epitope. (A) Both 1-22-3 and OX-7 react with 28 kD Thy-1 molecules in RIPA extract of mesangial cells.
Control antibodies RVG1 (IgG1), and AD-4 (IgG3) did not react with the RIPA extract of mesangial cells. (B to F) Total lysate from Escherichia coli
BL21 expressing glutathione-S-transferase (GST)-truncated Thy-1 were separated by sodium dodecyl sulfate-polyacrylamide gel electrophoresis
(SDS-PAGE) and immunoblotted with 1-22-3, OX-7, and AD-4. (G) Schematic representation of GST-truncated Thy-1. Closed bar represents
GST-truncatedThy-1 that was reacted with1-22-3.
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Fig. 3. Binding of 1-22-3 to the synthetic peptide. 1-22-3 binds to the
synthetic peptide 15LRLDCRHEN23 but not to 59RVNLFSDRF67.
OX-7 bound neither to LRLDCRHEN nor to RVNLFSDR.
Binding of 1-22-3 to mutated rat Thy-1 expressed
COS cells
We made series of plasmids that could express mu-
tated rat Thy-1 protein on COS using mammalian cell
expression vector pCDM8. These proteins are anchored
to the cell surface via GPI-anchor. 1-22-3 reacted the rat
Thy-1 and the FLAG-tagged rat Thy-1 (Fig.5A and B).
Recently it has been reported that Thy-1 binds to integrin-
b 3 through Arg-Leu-Asp (RLD) sequence of Thy-1. It is
reported that, when RLD sequence was changed to Arg-
Leu-Glu (RLE), the binding between Thy-1 and integrin-
b 3 was lost [20]. We made mutated rat Thy-1 whose
RLD sequence was changed to RLE to know whether
this change could influence the 1-22-3 reactivity. 1-22-3
bound to this mutated rat Thy-1. The results of GST-Thy-
1 fusion protein experiments showed that the removal
of residue 15 resulted the dramatic reduction of reactiv-
ity of 1-22-3 to the fusion proteins. Then we made the
mutated Thy-1 whose 15 leucine was changed to argi-
nine or glutamic acid or deleted. To make sure that the
mutated rat Thy-1 is expressed on COS cells, first we
made pCDM8FLAG-rThy-1. This plasmid could express
FLAG-tagged rat Thy-1 when transfected to COS cells.
We made then these FLAG-tagged mutated rat Thy-1
constructs. We confirmed the expression of FLAG-tagged
rat Thy-1 on COS cells with anti-FLAG antibody (Fig.
5D). However, 1-22-3 did not bind these mutated rat Thy-
1 (Fig. 5C). 1-22-3 and anti-FLAG antibody did not bind
the COS cells that was trasfected with pCDM8 (data not
shown).
DISCUSSION
In the present study, we determined the amino acid
sequence of the epitope recognized by monoclonal an-
tibody 1-22-3. A series of GST-truncated-Thy-1 fusion
proteins were generated. Western blot analysis showed
that 1-22-3 binds to the fusion proteins which contained
residues 15–23(LRLDCRHEN) of rat Thy-1 protein
[GST-rThy-1 (15–23)]. ELISA revealed that 1-22-3 binds
to GST-rThy-1 (15–23), but not to fusion proteins which
do not contain these residues. GST-rThy-1 (15–23) and
the synthetic peptide LRLDCRHEN could, but nonrele-
vant peptide RVNLFSDRF could not, inhibit the binding
of 1-22-3 to the mesangial cells. We also confirmed that
these sequence was included in 1-22-3 epitope using mu-
tated rat Thy-1 expressed on COS cells using mammalian
cell expression vector. The results demonstrate that 1-
22-3 recognized residues 15–23 (LRLDCRHEN) of rat
Thy-1.
Thy-1 consists of two b sheets with antiparallel b
strands. Thy-1 residues 15–23 correspond to the b strand
which forms b sheets with residues 4–11 and 68–72 [21].
1-22-3 binds to the b strands directly. Thy-1 has two allelic
forms, designated Thy-1.1 and Thy-1.2 in the mouse [22,
23]. OX-7 detects an allelic variation in mouse, Thy-1.1.
The difference in the primary sequence between Thy-1.1
and Thy-1.2 in the mouse is an arginine (Thy-1.1)/glycine
(Thy-1.2) exchange at residue 89 [21]. Rat Thy-1, which
bears the Thy-1.1 but not the Thy-1.2 determinant, also
has an arginine residue at 88, which is the equivalent po-
sition to arginine 89 in mouse Thy-1.1 [21]. Position 88
on rat Thy-1.1 is included in the region that is postulated
to connect b strands, and this site occurs on a sequence
loop outside the membrane, this may be included in the
OX-7 epitope. Antibody cross-linking of GPI-anchored
proteins, including Thy-1, leads to protein phosphoryla-
tion, intracellular calcium mobilization [24]. The exact
mechanism of signal transduction in GPI-anchor protein
is not yet known. The current understanding of the GPI-
anchored protein signaling process is that cross-linking
leads to coalescence of microdomains, which generates
threshold levels of activation signals through clustered
microdomainassociated Src family protein tyrosine ki-
nases (PTKs) [25, 26].
We speculate that the difference of the binding site
of antibody may affect the coalescence rate and the ef-
ficiency of signal transduction, although we do not have
direct evidence.
The cleavage of the GPI-anchor from Thy-1 resulted
in a loss of antigenic activity, detected by OX-7 [27, 28].
This suggests that the epitope, which was recognized by
OX-7, may be conformational dependent. In our study,
OX-7 bound to GST-rThy-1 (1–111), but bound nei-
ther to GST-rThy-1 (1–55) nor to GST-rThy-1 (52–111).
The epitope that was recognized by OX-7 may require
both parts and residues 52–111 may be not sufficient to
form the structure recognized by OX-7. OX-7 bound to
mutated Thy-1, whose GPI-anchor was replaced by the
three amino acids Gly Gly Ser [29], and also bound to
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Fig. 4. LRLDCHREN blocks the binding of 1-22-3 to rat mesangial cells. 15LRLDCHREN23 peptide (A) inhibits the binding of 1-22-3 to rat
mesangial cells in a dose dependent manner, but 59RVNLFSDRF67 peptide (B) had no effect on the binding. Both peptides had no effect on the
binding of OX-7 to rat mesangial cells. ∗P < 0.05 compared to control (N = 4).
Thy-1-immunoglobulin fusion protein [30]. The extra
amino acids or protein presumably stabilize the Thy-1
in a similar manner to the GPI anchor [29]. In our ex-
periment, GST may have stabilized the Thy-1 in a similar
manner to the GPI anchor.
The biologic significance of the Thy-1 molecule on
rat glomerular mesangial cells remains unknown, al-
though a rat model of anti-Thy-1 antibody induced
glomerulonephritis with mesangial cell injury has been
established and utilized to clarify the mechanisms respon-
sible for mesangial cell injury and inflammation [31–33].
We have reported that administration of a single injec-
tion of the monoclonal antibody against Thy-1 antigen
used in the present study, 1-22-3, induced massive pro-
teinuria in rats and that the nephritogenicity of this mon-
oclonal antiboy, assessed by estimating the severity of
proteinuria and glomerular inflammation induced after
injection, appeared to be higher than that caused by the
well-known anti-Thy-1.1 monoclonal antibody OX-7 [17,
34]. The different nephritogenicities of these two mono-
clonal antibodies may be explained by differences in their
complement-fixing activities, which are dependent on the
IgG subclass: 1-22-3 belongs to the IgG3 subclass and OX-
7 is an IgG1.In fact, an in vitro complement-dependent
cytotoxicity assay showed that 1-22-3 had higher cyto-
toxic activity against cultured rat mesangial cells than the
OX-7 (preliminary experiment). However, another pos-
sibility is that the specific epitope recognized by 1-22-3 is
a critical epitope for mesangial cell function.
We have shown, using whole antibody, that 1-22-3 and
OX-7 induced the calcium increase in mesangial cells. The
peak level of calcium concentration and the sustained
duration of calcium increase was much greater than 1-
22-3. The shape of curves of the calcium response was
A B
DC
Fig. 5. COS cells were transfected with mutated rat Thy-1 expressing
plasmids. (A) RatThy-1. (B) FLAG tagged rat Thy-1. (C) FLAG-tagged
rat Thy-1 (15L-R). (D) FLAG-tagged rat Thy-1 (15L-R). COS cells
were stained with 1-22-3 [10 lg/mL in Dulbecco’s modified Eagle’s
medium (DMEM) containing 0.1% azide (DME azide)] (A to C) or
anti-FLAG polyclonal antibody (50 lg/mL in DME azide) (D),washed
with DME azide three times and then stained with fluorescein isoth-
iocyanate (FITC)-labeled antimouse IgG antibody for 1-22-3 or FITC-
labeled antirabbit IgG antibody for anti-FLAG antibody (original mag-
nification ×400).
not exactly the same as that in previous experiment. This
difference may explain that the different preparation of
antibodies and the method we used for measuring the cal-
cium might influence the results. We could not completely
exclude the effect of complement using whole antibod-
ies. Then, in the present paper using F(ab’)2 antibodies,
we showed that both 1-22-3 and OX-7 could increase the
intracellular free calcium concentration. 1-22-3 induced
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a sustained increase in calcium concentration, while that
induced by OX-7 was transient, lasting 1 minute, then de-
creased to basal level. We have also found that, in serum-
free conditions, incubation of mesangial cells with 1-22-3
resulted in a significantly increased inositol-1,4,5 triphos-
phate (IP3) level and phosphorylation of src kinases, than
seen with OX-7 [14, 35]. These results suggested that the
epitope recognized by 1-22-3 effectively transduce signals
in mesangial cells, independent of complement.
Previously we have reported that the epitope recog-
nized by 1-22-3 was concentrated at the site on the cell
surface that faced the neighboring endothelial cells, when
cocultured with vascular endothelial cells [36]. In addi-
tion, mesangial cell proliferation regressed as a result of
intercellular contact with endothelial cells [37], although
the molecular mechanism of cell contact-dependent
growth inhibition remains unclear. In the present study,
we showed that 1-22-3 could partially inhibit the binding
of mesangial cells to endothelial cells. These data sug-
gest that the epitope may be important for mesangial-
endothelial cell interactions.
The ligand of Thy-1 has not been totally clarified. Ho-
mophilic interaction of Thy-1 could be one of the candi-
dates [38]. Recently, Leyton et al [20] reported that Thy-1
binds to integrin-b 3 and triggers tyrosine phosphoryla-
tion of focal adhesion proteins in astrocytes. Thy-1 has an
RGD-like sequence RLD. Through the RLD sequence,
Thy-1 binds to integrin-b 3 [20]. This RLD sequence was
contained in the epitope that was recognized by 1-22-3.
However, rat glomerular endothelial cells and cultured
rat aortic endothelial cells did not express integrin-b 3
in our experimental conditions. And Thy-1 was not ex-
pressed on cultured rat aortic cells in our experimental
condition. Further studies are needed to clarify the ligand
molecule of Thy-1 expressed on the rat mesangial cells.
Taken together, we speculate that disturbances of
communication between mesangial and endothelial cells,
caused by impairment of vascular regeneration [39] and
matrix remodeling, may induce pathological expansion of
the mesangium, eventually leading to glomerulosclerosis.
Analysis of the molecular mechanisms involved in en-
dothelial and mesangial cell contact, including Thy-1
molecules, may help us to understand the mechanisms
and develop new strategies for inhibition of progressive
glomerulosclerosis.
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